Carbonic anhydrase inhibitors and amobarbital resistance.
Ringman
John M
JM
Grant
Arthur C
AC
D000654:Amobarbital / Q000493:pharmacokinetics / Q000494:pharmacology*; D001931:Brain Mapping / Q000379:methods*; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D002343:Carotid Artery, Internal; D002540:Cerebral Cortex / Q000187:drug effects* / Q000503:physiopathology / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004827:Epilepsy / Q000175:diagnosis* / Q000503:physiopathology / Q000601:surgery; D007839:Functional Laterality / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000493:pharmacokinetics / Q000494:pharmacology*; D007269:Injections, Intra-Arterial; D008568:Memory / Q000187:drug effects*; D011300:Preoperative Care
D002257:Carbonic Anhydrase Inhibitors; D006993:Hypnotics and Sedatives; D000654:Amobarbital